MedTech companies have the goal of developing improvements in the way that human health can be managed. They do this across health systems that vary by market, in a world of constantly evolving medical and technology innovation, and where customers often ‘mix and match’ instruments by indication. In this environment, how do you develop a pricing strategy for your new technology that maximizes your ability to reach your company’s financial goals? Our client, a multi-billion-dollar global MedTech company, had recently developed advanced concepts for a new portfolio of lab technologies designed to provide rapid identification of potentially life-threatening infections. The company needed to make strategic decisions about the development and pricing of these technologies given

Join for free to read